BridgeMD
New treatment option for Liver Cirrhosis
Official title Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients
ClinicalTrials.gov ID: NCT07252102
What this study is testing
- What it's testing
- High flow nasal cannula oxygenation (HFNC) offers high flow and concentration oxygen delivery, providing excellent non-respiratory oxygenation. As a relatively new oxygen delivery method, it has gained widespread use.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- 18≤ age ≤80, gender is not limited;
- Patients undergoing elective gastroenteroscopy or treatment;
- ASA grade Ⅲ\~Ⅳ;
- 18 kg/m2≤BMI≤28kg/m2;
- The operation time of gastroenteroscopy is expected to be no more than 60min;
You likely can't join if
- Patients with nasal congestion, nasal bleeding, recent nasal trauma, recent nasal surgery, increased intracranial pressure and skull fracture, etc...
- acute respiratory infections and asthma attacks;
- Patients diagnosed with COPD;
- Clear difficult airway;
- Acute upper gastrointestinal bleeding with shock;
- Gastrointestinal obstruction with gastric content retention;
See the full eligibility criteria
- 18≤ age ≤80, gender is not limited;
- Patients undergoing elective gastroenteroscopy or treatment;
- ASA grade Ⅲ\~Ⅳ;
- 18 kg/m2≤BMI≤28kg/m2;
- The operation time of gastroenteroscopy is expected to be no more than 60min;
- Clearly understand, voluntarily participate in the study, and have informed consent from myself or my family members.
- Patients with nasal congestion, nasal bleeding, recent nasal trauma, recent nasal surgery, increased intracranial pressure and skull fracture, etc., who can not perform high-flow nasal catheter oxygen;
- acute respiratory infections and asthma attacks;
- Patients diagnosed with COPD;
- Clear difficult airway;
- Acute upper gastrointestinal bleeding with shock;
- Gastrointestinal obstruction with gastric content retention;
- Allergic to sedatives such as propofol;
- Persons with no capacity for civil conduct such as cognitive dysfunction.
The study team makes the final eligibility decision.
Where it's taking place
- Shenzhen, Guangdong, China
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenzhen, Guangdong, China; Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.